These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17454011)

  • 21. Investigation of the origin of ephedrine and methamphetamine by stable isotope ratio mass spectrometry: a Japanese experience.
    Makino Y; Urano Y; Nagano T
    Bull Narc; 2005; 57(1-2):63-78. PubMed ID: 21338016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The danger next door: methamphetamine.
    Clark J
    RN; 2008 May; 71(5):22-7; quiz 28. PubMed ID: 18564774
    [No Abstract]   [Full Text] [Related]  

  • 26. The War on Drugs: Methamphetamine, Public Health, and Crime.
    Dobkin C; Nicosia N
    Am Econ Rev; 2009 Mar; 99(1):324-349. PubMed ID: 20543969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.
    Wu LT; Blazer DG; Stitzer ML; Patkar AA; Blaine JD
    Am J Addict; 2008; 17(4):304-11. PubMed ID: 18612886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia.
    Fraser S; Moore D
    Int J Drug Policy; 2011 Nov; 22(6):498-506. PubMed ID: 22054738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of methamphetamine abuse: can existing evidence inform community prevention?
    Birckmayer J; Fisher DA; Holder HD; Yacoubian GS
    J Drug Educ; 2008; 38(2):147-65. PubMed ID: 18724655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring the stability of illicit drug markets: why does it matter?
    Brownstein HH; Taylor BG
    Drug Alcohol Depend; 2007 Sep; 90 Suppl 1():S52-60. PubMed ID: 17175119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A few minutes with Sen. Julie Rosen.
    Mrachek M
    Minn Med; 2014 Mar; 97(3):32-3. PubMed ID: 24720065
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 'real bad' drug.
    Smith SD
    Minn Med; 2005 Aug; 88(8):6-7. PubMed ID: 16225323
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudoephedrine laws in the US--are we doing enough?
    Murty S; Sansgiry SS
    Ann Pharmacother; 2006 Jun; 40(6):1213-5. PubMed ID: 16735651
    [No Abstract]   [Full Text] [Related]  

  • 35. The scourge of methamphetamine.
    Thomas SP
    Issues Ment Health Nurs; 2009 Aug; 30(8):473. PubMed ID: 19591019
    [No Abstract]   [Full Text] [Related]  

  • 36. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
    Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
    Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National drug abuse situation in Vietnam--how accurate are the projections?
    Ray R
    Addiction; 2008 Apr; 103(4):544-5. PubMed ID: 18339099
    [No Abstract]   [Full Text] [Related]  

  • 38. Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health.
    Plüddemann A; Myers BJ; Parry CD
    Drug Alcohol Rev; 2008 Mar; 27(2):185-9. PubMed ID: 18264880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 40. Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey.
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Wada K; Hirayasu Y
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):526-32. PubMed ID: 18950371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.